VETOQUINOL Corporate brochure 2010 (year 2009)
AN INDEPENDENT BRAND 11 th LARGEST VETERINARY PHARMACEUTICAL COMPANY IN THE WORLD // 3 rd LARGEST ANIMAL HEALTH SPECIALIST // 1,550 EMPLOYEES // A PRESENCE IN 23 COUNTRIES // 5% EFFECTIVE MARKET SHARE // REVENUES OF € 252.2 MILLION, OF WHICH OVER 80% IS GENERATED ABROAD // No 2 IN POLAND // No 3 IN CANADA // No 5 IN FRANCE // No 6 IN IRELAND AND SWITZERLAND // No 7 IN GERMANY, ITALY AND AUSTRIA // No 1 IN EUROPE FOR FOOD SUPPLEMENTS AND METABOLIC MODIFIERS // No 3 N EUROPE FOR ANTIBIOTICS. The 11 th largest veterinary pharmaceutical company in the world and the 3 rd largest dedicated to animal health, Vétoquinol is first and foremost an independent, family-owned business. Deeply committed to its values, it has always enjoyed a close relationship with its vet clients. Vétoquinol’s growth and development strategy focuses on innovation and finding the right balance between two major markets: companion animals and livestock, bred for human food. Historically based in France, Vétoquinol currently develops, produces and distributes a wide range of more than 700 medical and non-medical products in Europe, North America and Asia-Pacific. With a presence in 23 countries through its subsidiaries, its strong network of 140 distributor partners provides visibility for its products in more than 100 countries. PROFILE ACTIVITY REPORT 2009 01
Made with FlippingBook
RkJQdWJsaXNoZXIy NTkwMjY=